Kyorin Pharmaceutical Co., Ltd. and BioLeap Enter Research Collaboration
1/9/2012 6:30:16 AM
More...
|
Southern Research Institute Signs Agreement with BioLeap for Fragment-Based Drug Design Technology
12/13/2011 11:02:04 AM
More...
|
BioLeap Technology Aids Drug Discovery, GlaxoSmithKline (GSK) and Unilever (UN) Amongst Early Adopters
8/24/2011 8:25:48 AM
More...
|
BioLeap Moves Headquarters and Expands Staff to Meet Demand for Its Novel Molecular-Design Services
6/14/2011 7:44:28 AM
More...
|
BioLeap Names Keith Mackay as Vice President for Sales in Next Step to Further Commercialize Novel Molecular Design
5/4/2011 10:30:35 AM
More...
|
BioLeap Enters into Research Collaboration with Syngenta on Molecular Design of Crop Protection Products
4/5/2011 8:31:00 AM
More...
|
BioLeap Announces the Addition of Dr. Gene Cordes to Its Board of Directors
5/3/2010 9:12:42 AM
More...
|
BioLeap Secures $5M Series A Financing from Adams Capital Management and Quaker BioVentures, Inc.
1/12/2010 9:53:08 AM
More...
|
BioLeap Wins GlaxoSmithKline (GSK) Contract to Design Novel Lead Compounds for Previously Intractable Targets for Important Unmet Medical Needs
9/8/2009 1:39:02 PM
More...
|